Skip to main content
. 2017 Nov 23;7:16115. doi: 10.1038/s41598-017-16394-2

Figure 1.

Figure 1

Cells expressing wild type p53 show reduced sensitivity to inhibitors, GSK461364 and BI6727. (A,B,E) Parental HCT116 (p53+/+) cells and a derivative line lacking p53 expression (p53−/−) were treated for 72 h with increasing concentrations of the PLK1 inhibitors, GSK461364 (A) or BI6727 (B), or with taxol (E). Cell viability was then measured using an MTS assay. (C,D,F) HCT116-p53+/+ or -p53−/− cells treated for 72 h with increasing concentrations of GSK461364 (C), BI6727 (D) or taxol (F). Following removal of drugs, cells were grown for a further 12 days. Surviving colonies were detected by staining with crystal violet. Data are representative of three independent experiments each conducted in duplicate.